These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 17968740

  • 1. Challenges for blood-brain barrier (BBB) screening.
    Jeffrey P, Summerfield SG.
    Xenobiotica; 2007; 37(10-11):1135-51. PubMed ID: 17968740
    [Abstract] [Full Text] [Related]

  • 2. Assessment of the blood-brain barrier in CNS drug discovery.
    Jeffrey P, Summerfield S.
    Neurobiol Dis; 2010 Jan; 37(1):33-7. PubMed ID: 19664709
    [Abstract] [Full Text] [Related]

  • 3. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W, Potschka H.
    Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
    [Abstract] [Full Text] [Related]

  • 4. Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept.
    Reichel A.
    Chem Biodivers; 2009 Nov; 6(11):2030-49. PubMed ID: 19937839
    [Abstract] [Full Text] [Related]

  • 5. Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain.
    Summerfield SG, Stevens AJ, Cutler L, del Carmen Osuna M, Hammond B, Tang SP, Hersey A, Spalding DJ, Jeffrey P.
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1282-90. PubMed ID: 16330496
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pathophysiology of the blood-brain barrier: animal models and methods.
    Hawkins BT, Egleton RD.
    Curr Top Dev Biol; 2008 Mar; 80():277-309. PubMed ID: 17950377
    [Abstract] [Full Text] [Related]

  • 12. Progress in brain penetration evaluation in drug discovery and development.
    Liu X, Chen C, Smith BJ.
    J Pharmacol Exp Ther; 2008 May; 325(2):349-56. PubMed ID: 18203948
    [Abstract] [Full Text] [Related]

  • 13. Strategies to optimize brain penetration in drug discovery.
    Liu X, Chen C.
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):505-12. PubMed ID: 16022187
    [Abstract] [Full Text] [Related]

  • 14. [Biology of the blood-brain barrier: Part I].
    Weiss N, Miller F, Cazaubon S, Couraud PO.
    Rev Neurol (Paris); 2009 Nov; 165(11):863-74. PubMed ID: 19427009
    [Abstract] [Full Text] [Related]

  • 15. Blood-brain barrier in vitro models as tools in drug discovery: assessment of the transport ranking of antihistaminic drugs.
    Neuhaus W, Mandikova J, Pawlowitsch R, Linz B, Bennani-Baiti B, Lauer R, Lachmann B, Noe CR.
    Pharmazie; 2012 May; 67(5):432-9. PubMed ID: 22764578
    [Abstract] [Full Text] [Related]

  • 16. Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction.
    Summerfield SG, Read K, Begley DJ, Obradovic T, Hidalgo IJ, Coggon S, Lewis AV, Porter RA, Jeffrey P.
    J Pharmacol Exp Ther; 2007 Jul; 322(1):205-13. PubMed ID: 17405866
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Kinetic evidence for active efflux transport across the blood-brain barrier of quinolone antibiotics.
    Ooie T, Terasaki T, Suzuki H, Sugiyama Y.
    J Pharmacol Exp Ther; 1997 Oct; 283(1):293-304. PubMed ID: 9336336
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.